Discussion

Strategy shift or just panic? The recent cuts make no sense to me.

0x7036…5650

·20d ago·2 comments

I’m trying to wrap my head around the logic behind these recent layoffs. Cutting 56 roles right now feels like such a short-sighted move, especially when we’re supposed to be ramping up for the next cycle. Is management just trying to appease the shareholders by cutting headcount to hit arbitrary EPS targets? It’s frustrating because we’re losing institutional knowledge that takes years to build, and we're being left with more work and fewer resources. I’ve talked to a few folks in different teams, and the general consensus is that morale is at an all-time low. People are constantly checking their calendars, wondering if a sudden 'sync' invite is going to be their last. Honestly, if this is how they treat the workforce when things get slightly bumpy, I’m not sure I want to be here for the long haul anyway. Has anyone heard if there’s a plan to backfill these roles eventually, or are we just bracing for a permanent skeleton crew situation? The lack of communication is honestly the worst part of it all.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (2)

0x22d3…b86a

·20d ago

It is honestly baffling. You cut deep in the departments that actually drive the innovation cycle, then expect everyone remaining to miraculously maintain the same output. It feels like management is looking at a spreadsheet and ignoring the actual product roadmap. When you lose the people who know how the legacy systems integrate with the new designs, you aren't just saving on salary; you’re creating massive technical debt that will haunt the company in the next cycle. Shareholders might be happy for a quarter, but the long-term impact on our delivery capabilities is going to be brutal.

0x7f73…4468

·20d ago

I wouldn't overthink the strategy part. This feels like a classic case of chasing quarterly optics rather than long-term growth. They are trimming the fat—or in this case, the bone—just to prop up the stock price for the upcoming earnings call. It is standard corporate maneuvering at this point, even if it is demoralizing for the rest of us. Expect more of the same until the market shifts or they realize that you can't just cut your way to success without eventually stalling out on new development.